129 related articles for article (PubMed ID: 37791396)
21. Serum Calcification Propensity and Clinical Events in CKD.
Bundy JD; Cai X; Mehta RC; Scialla JJ; de Boer IH; Hsu CY; Go AS; Dobre MA; Chen J; Rao PS; Leonard MB; Lash JP; Block GA; Townsend RR; Feldman HI; Smith ER; Pasch A; Isakova T;
Clin J Am Soc Nephrol; 2019 Nov; 14(11):1562-1571. PubMed ID: 31658949
[TBL] [Abstract][Full Text] [Related]
22. Association Between Moderate-to-Vigorous Physical Activity and the Risk of Major Adverse Cardiovascular Events or Mortality in People With Various Metabolic Syndrome Status: A Nationwide Population-Based Cohort Study Including 6 Million People.
Park S; Han K; Lee S; Kim Y; Lee Y; Kang MW; Park S; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
J Am Heart Assoc; 2020 Nov; 9(22):e016806. PubMed ID: 33153387
[TBL] [Abstract][Full Text] [Related]
23. Obesity measures, metabolic health and their association with 15-year all-cause and cardiovascular mortality in the SAMINOR 1 Survey: a population-based cohort study.
Michalsen VL; Wild SH; Kvaløy K; Svartberg J; Melhus M; Broderstad AR
BMC Cardiovasc Disord; 2021 Oct; 21(1):510. PubMed ID: 34674643
[TBL] [Abstract][Full Text] [Related]
24. Geriatric Nutritional Risk Index Is Associated with Unique Health Conditions and Clinical Outcomes in Chronic Kidney Disease Patients.
Lin TY; Hung SC
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31739530
[TBL] [Abstract][Full Text] [Related]
25. Visit-to-visit variability in estimated glomerular filtration rate predicts hospitalization and death due to cardiovascular events.
Suzuki A; Obi Y; Hayashi T; Kotani N; Uemura Y; Imai E; Makino H; Hishida A
Clin Exp Nephrol; 2019 May; 23(5):661-668. PubMed ID: 30687876
[TBL] [Abstract][Full Text] [Related]
26. Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA
Rosenstock J; Perkovic V; Alexander JH; Cooper ME; Marx N; Pencina MJ; Toto RD; Wanner C; Zinman B; Baanstra D; Pfarr E; Mattheus M; Broedl UC; Woerle HJ; George JT; von Eynatten M; McGuire DK;
Cardiovasc Diabetol; 2018 Mar; 17(1):39. PubMed ID: 29540217
[TBL] [Abstract][Full Text] [Related]
27. Obesity and risk of end-stage renal disease in patients with chronic kidney disease: a cohort study.
Lin TY; Liu JS; Hung SC
Am J Clin Nutr; 2018 Nov; 108(5):1145-1153. PubMed ID: 30321257
[TBL] [Abstract][Full Text] [Related]
28. Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 studies.
Osadnik K; Osadnik T; Gierlotka M; Windak A; Tomasik T; Mastej M; Kuras A; Jóźwiak K; Penson PE; Lip GYH; Mikhailidis DP; Toth PP; Catapano AL; Ray KK; Howard G; Tomaszewski M; Charchar FJ; Sattar N; Williams B; MacDonald TM; Banach M; Jóźwiak J
Eur J Prev Cardiol; 2023 Sep; 30(12):1195-1204. PubMed ID: 37039119
[TBL] [Abstract][Full Text] [Related]
29. Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.
Srivastava A; Kaze AD; McMullan CJ; Isakova T; Waikar SS
Am J Kidney Dis; 2018 Mar; 71(3):362-370. PubMed ID: 29132945
[TBL] [Abstract][Full Text] [Related]
30. Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort.
Pammer LM; Lamina C; Schultheiss UT; Kotsis F; Kollerits B; Stockmann H; Lipovsek J; Meiselbach H; Busch M; Eckardt KU; Kronenberg F;
J Intern Med; 2021 Dec; 290(6):1219-1232. PubMed ID: 34342064
[TBL] [Abstract][Full Text] [Related]
31. Metabolic syndrome and all-cause and cardiovascular disease mortality: Japan Public Health Center-based Prospective (JPHC) Study.
Saito I; Iso H; Kokubo Y; Inoue M; Tsugane S
Circ J; 2009 May; 73(5):878-84. PubMed ID: 19282609
[TBL] [Abstract][Full Text] [Related]
32. Chronic kidney disease progression and mortality risk profiles in Germany: results from the Chronic Kidney Disease Outcomes and Practice Patterns Study.
Reichel H; Zee J; Tu C; Young E; Pisoni RL; Stengel B; Duttlinger J; Lonnemann G; Robinson BM; Pecoits-Filho R; Fliser D
Nephrol Dial Transplant; 2020 May; 35(5):803-810. PubMed ID: 31953939
[TBL] [Abstract][Full Text] [Related]
33. Serum aldosterone and death, end-stage renal disease, and cardiovascular events in blacks and whites: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Deo R; Yang W; Khan AM; Bansal N; Zhang X; Leonard MB; Keane MG; Soliman EZ; Steigerwalt S; Townsend RR; Shlipak MG; Feldman HI;
Hypertension; 2014 Jul; 64(1):103-10. PubMed ID: 24752431
[TBL] [Abstract][Full Text] [Related]
34. Low-grade inflammation, metabolic syndrome and the risk of chronic kidney disease: the 2005 Korean National Health and Nutrition Examination Survey.
Kang HT; Kim JK; Shim JY; Lee HR; Linton JA; Lee YJ
J Korean Med Sci; 2012 Jun; 27(6):630-5. PubMed ID: 22690094
[TBL] [Abstract][Full Text] [Related]
35. Extracellular fluid volume is associated with incident end-stage kidney disease and mortality in patients with chronic kidney disease.
Faucon AL; Flamant M; Metzger M; Boffa JJ; Haymann JP; Houillier P; Thervet E; Vrtovsnik F; Stengel B; Geri G; Vidal-Petiot E;
Kidney Int; 2019 Oct; 96(4):1020-1029. PubMed ID: 31477263
[TBL] [Abstract][Full Text] [Related]
36. Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies.
Minutolo R; Gabbai FB; Provenzano M; Chiodini P; Borrelli S; Garofalo C; Sasso FC; Santoro D; Bellizzi V; Conte G; De Nicola L
Nephrol Dial Transplant; 2018 Nov; 33(11):1942-1949. PubMed ID: 29509925
[TBL] [Abstract][Full Text] [Related]
37. Cardiometabolic Risk Factors, Metabolic Syndrome, and Chronic Kidney Disease Progression in Children.
Lalan S; Jiang S; Ng DK; Kupferman F; Warady BA; Furth S; Mitsnefes MM
J Pediatr; 2018 Nov; 202():163-170. PubMed ID: 30041938
[TBL] [Abstract][Full Text] [Related]
38. Sex disparities and adverse cardiovascular and kidney outcomes in patients with chronic kidney disease: results from the KNOW-CKD.
Jung CY; Heo GY; Park JT; Joo YS; Kim HW; Lim H; Chang TI; Kang EW; Yoo TH; Kang SW; Lee J; Kim SW; Oh YK; Jung JY; Oh KH; Ahn C; Han SH
Clin Res Cardiol; 2021 Jul; 110(7):1116-1127. PubMed ID: 34003323
[TBL] [Abstract][Full Text] [Related]
39. Association of Prediabetes With CKD Progression and Adverse Cardiovascular Outcomes: An Analysis of the CRIC Study.
Neves JS; Correa S; Baeta Baptista R; Bigotte Vieira M; Waikar SS; Mc Causland FR
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1772-80. PubMed ID: 31943096
[TBL] [Abstract][Full Text] [Related]
40. Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease.
Seiler-Mussler S; Limbach AS; Emrich IE; Pickering JW; Roth HJ; Fliser D; Heine GH
Clin J Am Soc Nephrol; 2018 Apr; 13(4):569-576. PubMed ID: 29507005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
